The sleep aid Ambien could be allowing toxic proteins to pollute the brain, potentially increasing a person’s risk of disorders like Alzheimer’s disease.
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.